Background: Cancer of the Prostate is one of the leading cause of cancer death in men and its incidence rates are expected to continue escalating. Globally it is the second ... determine the pattern and distribution of…
Background: Prostate cancer is a significant healthcare burden in bothdeveloping and under developed countries. Efforts in Saudi Arabia may behindered by the unclarity of awareness of predictors of early prostate…
Current advents of new technology in prostate cancer treatment still carries many problems regarding oncological outcome: Local control remains elusive, with biochemical failure ultimately occurring in half of the…
Close urologic follow-up of renal transplant candidates and beneficiaries frequently uncovers prostate carcinoma at a beginning phase. Two patients who went through renal transplantation for end-stage illness…
Purpose: To study the association of prostatic volume, prostatomegaly grade and IPSS (International Prostate Symptom Score) with vitamin D deficiency if any. Materials and Methods: The study was conducted ... evaluation…
Introduction: Previous studies have suggested that smoking and drinking alcohol are prostate cancer risks. However, how regional unevenness of radiation oncologists/urologists in Japan or other risk factors including…
With 1.1 million known cases, prostate cancer is the second most common type of cancer among men. It is second only to lung cancer which affects over 1.2 million ... worldwide. African men suffer disproportionately from…
Background: AVODART After Radical Therapy For Prostate Cancer Study (ARTS) reported dutasteride reduced PSA Doubling (PSADT) at two years by 66% and disease progression by 59%. The durability ... impact of dutasteride…
combination) on the expression of OPN isoforms and VEGF. Methods: The human prostate cell lines were treated with different concentrations of Curcumin and prostate cancer conventional drug Flutamide alone…
Metastatic prostate cancer usually has a poor prognosis. Identification of new molecular signatures associated with an aggressive form of prostate cancer and the creation of a prognostic multigenic panel will ... panel…
Androgen blockade leads not only to the death of malignant prostate cells, but also to a violation of the division and differentiation of androgen-dependent cells (needing testosterone, formed ... degree of decrease in…
prostate cancer patients with radical prostatecomy, 1 year after surgery is the main recovery period for their physiological complications and psychological problems and maladaptation will seriously affect the quality…
several prognostic models for predicting overall survival (OS) of patients with metastatic castration-resistant prostate cancer (mCRPC). Circulating tumor cell (CTCs) enumeration at baseline and its conversion post…
dogs, and rats showed that the injection of botulinum neurotoxin type A into the prostate gland reduce the size and other biomarker that indicate botulinum neurotoxin type ... promising treatment for benign prostatic…
perioperative results of monopolar and bipolar trans urethral resection of prostrate (TURP) for benign prostatic hyperplasia (BPH) and evaluate the advantages of bipolar transurethral resection over the monopolar…